Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dirk Vordermark

Showing results (151-160 of 222) with videos related to

Pageof 23
Sort By:
Current Pharmaceutical Design|September 8, 2010
Modulation of carbonic anhydrase 9 (CA9) in human brain cancerHarun M Said, Claudiu T Supuran, Carsten Hageman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2006
Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levelsMatthias Bache, Rolf Reddemann, Harun M Said, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 10, 2014
Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patientsHenri Wichmann, Antje Güttler, Matthias Bache, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 24, 2007
Patterns of care in the radiotherapy of prostate cancer in Northern Bavaria 1998-2000Dirk Vordermark, Dorothee Marold, Susanne Wirth, et al.
Oncology Reports|May 13, 2015
mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastomaMatthias Bache, Swetlana Rot, Jacqueline Keßler, et al.
Cancers|December 11, 2025
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. <i>Cancers</i> 2023, <i>15</i>, 3448Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cancers|July 14, 2023
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint InhibitionJessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Radiation Oncology (London, England)|September 13, 2011
Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditionsMatthias Bache, Martin P Zschornak, Sarina Passin, et al.
Geburtshilfe Und Frauenheilkunde|June 17, 2024
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical CancerClemens Tempfer, Tanja Fehm, Dirk Vordermark, et al.
Annals of Surgical Oncology|March 30, 2002
An experimental evaluation of three preoperative radiation regimens for resectable rectal cancerGenc Basha, Willy Landuyt, Jack Fowler, et al.
Pageof 23

Showing results (151-160 of 222) with videos related to

Sort By:
Pageof 23
Current Pharmaceutical Design|September 8, 2010
Modulation of carbonic anhydrase 9 (CA9) in human brain cancerHarun M Said, Claudiu T Supuran, Carsten Hageman, et al.
International Journal of Radiation Oncology, Biology, Physics|October 24, 2006
Immunohistochemical detection of osteopontin in advanced head-and-neck cancer: prognostic role and correlation with oxygen electrode measurements, hypoxia-inducible-factor-1alpha-related markers, and hemoglobin levelsMatthias Bache, Rolf Reddemann, Harun M Said, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|April 10, 2014
Inverse prognostic impact of ErbB2 mRNA and protein expression level in tumors of soft tissue sarcoma patientsHenri Wichmann, Antje Güttler, Matthias Bache, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 24, 2007
Patterns of care in the radiotherapy of prostate cancer in Northern Bavaria 1998-2000Dirk Vordermark, Dorothee Marold, Susanne Wirth, et al.
Oncology Reports|May 13, 2015
mRNA expression levels of hypoxia-induced and stem cell-associated genes in human glioblastomaMatthias Bache, Swetlana Rot, Jacqueline Keßler, et al.
Cancers|December 11, 2025
Correction: Hassel et al. Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint Inhibition. <i>Cancers</i> 2023, <i>15</i>, 3448Jessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Cancers|July 14, 2023
Medical Needs and Therapeutic Options for Melanoma Patients Resistant to Anti-PD-1-Directed Immune Checkpoint InhibitionJessica C Hassel, Lisa Zimmer, Thomas Sickmann, et al.
Radiation Oncology (London, England)|September 13, 2011
Increased betulinic acid induced cytotoxicity and radiosensitivity in glioma cells under hypoxic conditionsMatthias Bache, Martin P Zschornak, Sarina Passin, et al.
Geburtshilfe Und Frauenheilkunde|June 17, 2024
Statement of the Uterus Commission of the Gynecological Oncology Working Group (AGO) on Neoadjuvant Chemotherapy Prior to Definitive Radiochemotherapy in Patients with Locally Advanced Cervical CancerClemens Tempfer, Tanja Fehm, Dirk Vordermark, et al.
Annals of Surgical Oncology|March 30, 2002
An experimental evaluation of three preoperative radiation regimens for resectable rectal cancerGenc Basha, Willy Landuyt, Jack Fowler, et al.
Pageof 23